BioNTech SE
(BNTX)
undefined
undefined%
At close: undefined
121.57
1.14%
After-hours Dec 13, 2024, 05:44 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Net Income | 1.19B | 12.95B | 15.05B | -145.80M | -179.44M | -47.66M | -85.91M |
Depreciation & Amortization | 183.40M | 123.30M | 75.20M | 38.74M | 33.90M | 21.98M | 10.53M |
Stock-Based Compensation | 51.40M | 108.60M | 93.90M | 32.10M | 30.23M | 7.64M | 5.91M |
Other Working Capital | - | -50.87M | - | - | - | - | - |
Other Non-Cash Items | -1.62B | -4.13B | 212.50M | 114.47M | 262.00K | -226.00K | -1.40M |
Deferred Income Tax | - | - | -3.79B | 40.06M | -54.00K | 1.04M | 26.27M |
Change in Working Capital | 5.57B | 4.52B | -10.73B | -93.10M | -83.44M | -40.96M | -7.96M |
Operating Cash Flow | 5.37B | 13.58B | 889.70M | -13.47M | -198.54M | -58.18M | -52.56M |
Capital Expenditures | -705.50M | -363.30M | -154.00M | -85.45M | -71.08M | -67.85M | -57.74M |
Acquisitions | -336.90M | 589.19K | -20.80M | -60.64M | -6.06M | 727.57K | 4.88M |
Purchase of Investments | -7.13B | -47.80M | -394.70M | - | - | - | - |
Sales Maturities Of Investments | 1.22B | 375.20M | 26.50M | - | - | - | - |
Other Investing Acitivies | -455.40M | 10.81K | -23.10M | 1.24M | 21.00K | 706.00K | 5.19M |
Investing Cash Flow | -6.95B | -35.30M | -566.10M | -144.85M | -77.11M | -67.15M | -52.55M |
Debt Repayment | -40.10M | -59.10M | -66.70M | 141.70M | 7.90M | 3.45M | -1.64M |
Common Stock Repurchased | -738.50M | -986.40M | - | - | - | - | - |
Dividend Paid | - | -475.58M | - | - | - | - | - |
Other Financial Acitivies | - | - | - | - | - | - | - |
Financial Cash Flow | -778.60M | -1.42B | 94.20M | 894.73M | 383.29M | 365.18M | -1.64M |
Net Cash Flow | -2.21B | 12.18B | 482.50M | 691.06M | 107.65M | 239.39M | -131.57M |
Free Cash Flow | 4.67B | 13.21B | 735.70M | -98.92M | -269.62M | -126.03M | -110.30M |